Skip to Main Content


Skip Nav Destination

Abstract P2-09-01: Subgroups analysis of a multicenter, prospective, randomized, blinded phase 2b trial of trastuzumab + nelipeptimut-S (NeuVax) vs trastuzumab for prevention of recurrence in breast cancer patients

Cancer Res (2019) 79 (4_Supplement): P2-09-01.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Mina Hosseini
  • Simin Seyedpour
  • Behzad Khodaei
  • Amir-Hossein Loghman
  • Nasrin Seyedpour
  • Mohammad-Hossein Yazdi
  • Nima Rezaei
Vaccines (2023) 11 (1): 146.
Close Modal

or Create an Account

Close Modal
Close Modal